{"id":"W2081276121","doi":"10.1056/nejmoa066224","title":"Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2942,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Rosiglitazone; Metformin; Glycemic; Diabetes mellitus; Internal medicine; Intensive care medicine; Pharmacology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}